Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;21(3):307-316.

Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?

Berat Uslu  1 , Askin Gülsen  2 , Burcu Arpinar Yigitbas  1
Affiliations

Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?

Berat Uslu et al. Tanaffos. 2022 Mar.

Abstract

Background: Acute exacerbation events, which can develop during the natural course of chronic obstructive pulmonary disease (COPD) can lead to worsening quality of life, increased hospital costs, and higher rates of morbidity and mortality. In recent years, individuals at heightened risk of COPD exacerbations have been said to display a so-called "frequent exacerbator (FE)" phenotype, defined as having two or more exacerbation events (or ≥ 1 exacerbation with a hospitalization) within 1 year.

Materials and methods: We conducted a retrospective study involving 299 patients with COPD. Patients were divided into 2 groups as non-exacerbator phenotype (group-1, n=195) and FE phenotype (group-2, n=104).

Results: FE phenotype was identified in 35.1% of patients. There were no significant differences between these two phenotypes in terms of gender, smoking status, or leukocyte count. However, FEs were found to be older (p=0.04), with more frequent detection of emphysema (p=0.02) and lower eosinophil levels (p=0.02). FEs also demonstrated worse pulmonary function parameters.

Conclusion: COPD patients with the FE phenotype likely require a different treatment algorithm due to differing clinical features such as poorer respiratory function, lower eosinophil levels, and more frequent emphysema.

Keywords: COPD; Clinical characteristic; Frequent exacerbator; Hospitalization; Phenotype.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Hospitalization and chronic obstructive pulmonary disease (COPD) exacerbation rates based on the (A) new Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) classification system and (B) GOLD 2007 classification
Figure 2.
Figure 2.
Frequency of inhaled corticosteroid treatment based on phenotype in patients with (A) Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) stage II, III, or IV disease and (B) GOLD stage III or IV disease
See this image and copyright information in PMC

References

    1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0w... (Accessed on Januar 30, 2021)
    1. Labaki WW, Martinez FJ. Time to Understand the Infrequency of the Frequent Exacerbator Phenotype in COPD. Chest 2018;153(5):1087–8. - PubMed
    1. Jinjuvadia C, Jinjuvadia R, Mandapakala C, Durairajan N, Liangpunsakul S, Soubani AO. Trends in Outcomes, Financial Burden, and Mortality for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) in the United States from 2002 to 2010. COPD 2017;14(1):72–9. - PMC - PubMed
    1. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. . Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363(12):1128–38. - PubMed
    1. Capozzolo A, Carratù P, Dragonieri S, Falcone VA, Quaranta VN, Liotino V, et al. . Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD. Respir Care 2017;62(5):572–8. - PubMed

LinkOut - more resources